| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281567 | Clinical Gastroenterology and Hepatology | 2015 | 31 Pages |
Abstract
On the basis of a meta-analysis, continued use of immunomodulator therapy after starting anti-TNF therapy is no more effective than anti-TNF monotherapy in inducing or maintaining response or remission. RCTs are needed to adequately assess the efficacy of continued immunomodulator therapy after anti-TNF therapy is initiated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jennifer L. Jones, Gilaad G. Kaplan, Laurent Peyrin-Biroulet, Leonard Baidoo, Shane Devlin, Gil Y. Melmed, Divine Tanyingoh, Laura Raffals, Peter Irving, Patricia Kozuch, Miles Sparrow, Fernando Velayos, Brian Bressler, Adam Cheifetz,